参考文献/References:
[1] Sitarz R,Skierucha M,Mielko J,et al.Gastric cancer:epidemiology,prevention,classification,and treatment[J].Cancer Manag Res,2018,10(2):239-248.
[2] Zeng H,Chen W,Zheng R,et al.Changing cancer survival in China during 2003-2015:a pooled analysis of 17 population-based cancer registries[J].Lancet Glob Health,2018,6(5):555-567.
[3] Mori G,Nakajima T,Asada K, et al.Incidence of and risk factors for metachronous gastric cancer after endoscopic resection and successful Helicobacter pylori eradication:results of a large-scale,multicenter cohort study in Japan[J].Gastric Cancer,2016,19(3):911-918.
[4] Kwon Y,Jeon S,Nam S,et al.Helicobacter pylori infection and serum level of pepsinogen are associated with the risk of metachronous gastric neoplasm after endoscopic resection[J].Aliment Pharmacol Ther,2017,46(8):758-767.
[5] Wightman B,Ha I,Ruvkun G.Posttranscriptional regulation of the heterochronic gene lin-14 by lin-4 mediates temporal pattern formation in C elegans [J].Cell,1993,75(5):855-862.
[6] Pasquinelli AE,Reinhart BJ,Slack F,et al.Conservation of the sequence and temporal expression of let-7 heterochronic regulatory RNA[J].Nature,2000,408(6808):86-89.
[7] Reinhart BJ,Slack FJ,Basson M,et al.The 21-nucleotide let-7 RNA regulates developmental timing in Caenorhabditis elegans[J].Nature,2000,403(6772):901-906.
[8] Slack FJ,Basson M,Liu Z,et al.The lin-41 RBCC gene acts in the C.elegans heterochronic pathway between the let-7 regulatory RNA and the LIN-29 transcription factor[J].Mol Cell,2000,5(4):659-669.
[9] Hutvagner G,Mc Lachlan J,Pasquinelli AE,et al.A cellular function for the RNA-interference enzyme Dicer in the maturation of the let-7 small temporal RNA[J].Science,2001,293(5531):834-838.
[10] Liu J,Liu F,Shi Y,et al.Identification of key miRNAs and genes associated with stomach adenocarcinoma from The Cancer Genome Atlas database[J].FEBS Open Bio,2018,8(2):279-294.
[11] Huo Q.Analysis of expression profile of miRNA in stomach adenocarcinoma[J].J Buon,2017,22(5):1154-1159.
[12] 王 勇,李宇男,于晓松. 肺癌细胞与组织中 miR-100、miR-148a的表达变化及临床意义[J].山东医药,2014,54(44):29-32.
[13] Cao YH,Zhang HH,Xu HF,et al.Prognostic role of microRNA-100 in patients with bladder cancer[J].Genet Mol Res,2015,14(4):15948-15954.
[14] La Conti JJ,Shivapurkar N,Preet A,et al.Tissue and serum microRNAs in the Kras(G12D)transgenic animal model and in patients with pancreatic cancer[J].PLoS One,2011,6(6):e20687.
[15] Panarelli NC,Chen YT,Zhou XK,et al.MicroRNA expression aids the preoperative diagnosis of pancreatic ductal adenocarcinoma[J].Pancreas,2012,41(5):685-690.
[16] Chen Z,Liu X,Hu Z,et al.Identification and characterization of tumor suppressor and oncogenic miRNAs in gastric cancer[J].Oncol Lett,2015,10(1):329-336.
[17] Ueda T,Volinia S,Okumura H,et al.Relation between microRNA expression and progression and prognosis of gastric cancer:a microRNA expression analysis[J].Lancet Oncol,2010,11(2):136-146.
[18] Vriens MR,Weng J,Suh I,et al.MicroRNA expression profiling is a potential diagnostic tool for thyroid cancer[J].Cancer,2012,118(13):3426-3432.
[19] Cao Y,Song J,Ge J,et al.MicroRNA-100 suppresses human gastric cancer cell proliferation by targeting CXCR7[J].Oncol Lett,2018,15(1):453-458.
[20] Yang G,Gong Y,Wang Q,et al.The role of miR-100-mediated Notch pathway in apoptosis of gastric tumor cells[J].Cell Signal,2015,27(6):1087-1101.
相似文献/References:
[1]侯洁心 ,郭萍△.免疫组化标志物Her2和肿瘤标志物在胃癌诊断中的价值分析*[J].陕西医学杂志,2019,(1):121.
HOU Jiexin,GUO Ping..The value of immunohistochemical marker Her2 andtumor markers in the diagnosis of gastric cancer[J].,2019,(7):121.
[2]唐亚荣.循环热灌注化疗联合替吉奥及热疗治疗老年胃癌癌性腹水临床研究*[J].陕西医学杂志,2019,(4):435.
TANG Yarong..Clinical effect analysis of combined therapy with tiago and hyperthermia in the treatment of malignant ascites in elderly patients with gastric cancer[J].,2019,(7):435.
[3]刘国庆,闫 龙△,高 任.1.5T磁共振扩散加权成像在胃癌淋巴结转移诊断中的应用价值*[J].陕西医学杂志,2019,(4):456.
LIU Guoqing,YAN Long,GAO Ren..1.5T magnetic resonance diffusion weighted imaging in the diagnosis of lymph node metastasis of gastric cancer[J].,2019,(7):456.
[4]胡乃军,王海龙.胃腺癌组织中MMP11、MMP12和VEGFD的表达及临床意义[J].陕西医学杂志,2019,(5):554.
[5]米志宽,赵菊梅.抑癌基因甲基化与胃癌关系研究进展*[J].陕西医学杂志,2019,(5):679.
MI Zhikuan,ZHAO Jumei..Research progress of relationships between tumor suppressor gene methylation and gastric cancer[J].,2019,(7):679.
[6]石颖鹏,王敏娟,李程亮.肠化生相关分子与胃癌的发生和进展研究概况[J].陕西医学杂志,2019,(7):958.
SHI Yingpeng,WANG Minjuan,LI Chengliang,et al.Intestinal metaplasia-related molecules and the occurrence and progress of gastric cancer[J].,2019,(7):958.
[7]郭小艳,于桂萍.抗幽门螺杆菌疗法联合新辅助化疗对胃癌术后疗效及患者血清VEGF、bFGF的影响[J].陕西医学杂志,2019,(8):1010.
GUO Xiaoyan,YU Guiping..Effect of anti-Helicobacter pylori therapy combined with neoadjuvant chemotherapy on serum VEGF and bFGF in postoperative patients with gastric cancer[J].,2019,(7):1010.
[8]柯东平,毛俊倩,郭甲民,等.SCNN1B与胃癌细胞上皮间质转化相关性实验研究*[J].陕西医学杂志,2019,(9):1115.
KE Dongping,MAO Junqian,GUO Jiamin,et al.Research on the correlation between SCNN1B and〖JZ〗 epithelialmesenchymal transformation in gastric cancer cells[J].,2019,(7):1115.
[9]王小林,马任远,张 哲.腹腔镜手术治疗老年进展期胃癌50例临床疗效分析[J].陕西医学杂志,2019,(10):1360.
[10]苏建淳,张国义,卢秋霞,等.miR-124在鼻咽癌组织中的表达及其与预后关系研究*[J].陕西医学杂志,2020,49(2):144.
SU Jianchun,ZHANG Guoyi,LU Qiuxia,et al.Expression of miR-124 in nasopharyngeal carcinoma and its relationship with prognosis[J].,2020,49(7):144.
[11]张鹏飞,刘新奇,石 菲.miR-35对胃癌细胞MNK-45凋亡的作用及机制探讨[J].陕西医学杂志,2022,51(2):239.[doi:DOI:10.3969/j.issn.1000-7377.2022.02.026]
ZHANG Pengfei,LIU Xinqi,SHI Fei.Effect and mechanism of miR-35 on apoptosis of gastric cancer cell line MNK-45[J].,2022,51(7):239.[doi:DOI:10.3969/j.issn.1000-7377.2022.02.026]